Peter Kojo Quashie
ASSOCIATE PROFESSOR
CollegeCOLLEGE OF BASIC & APPLIED SC.
School / InstituteCOLLEGE OF BASIC & APPLIED SC.
DepartmentWEST AFRICAN CENTRE FOR CELL BIOLOGY OF INFECTIOUS PATHOGENS
Virology
Publication activity
Publication statistics
Publications
114 matching publications
| Publication | Year | Journal | Thematic area | Citations |
|---|---|---|---|---|
| HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug SM Schader, SP Colby-Germinario, PK Quashie, M Oliveira, RI Ibanescu, ... |
2012 | Antimicrobial agents and chemotherapy 56 (8), 4257-4267, 2012 | Health Sciences | 37 |
| Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors SA Hassounah, T Mesplède, PK Quashie, M Oliveira, PA Sandstrom, ... |
2014 | Journal of virology 88 (17), 9683-9692, 2014 | Health Sciences | 32 |
| Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny M Hunt, AS Hinrichs, D Anderson, L Karim, BL Dearlove, J Knaggs, ... |
2026 | Nature methods 23 (3), 653-662, 2026 | Natural Sciences | 30 |
| Molecular mechanism of antagonism between the Y181C and E138K mutations in HIV-1 reverse transcriptase HT Xu, M Oliveira, EL Asahchop, M McCallum, PK Quashie, Y Han, ... |
2012 | Journal of virology 86 (23), 12983-12990, 2012 | Natural Sciences | 30 |
| Rapid, cheap, and effective COVID-19 diagnostics for Africa L Yusuf, M Appeaning, TG Amole, BM Musa, HS Galadanci, PK Quashie, ... |
2021 | Diagnostics 11 (11), 2105, 2021 | Natural Sciences | 29 |
| Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors YS Han, WL Xiao, PK Quashie, T Mesplède, H Xu, E Deprez, O Delelis, ... |
2013 | Antiviral research 98 (3), 441-448, 2013 | Health Sciences | 27 |
| Structural studies of the HIV-1 integrase protein: compound screening and characterization of a DNA-binding inhibitor PK Quashie, YS Han, S Hassounah, T Mesplède, MA Wainberg |
2015 | Plos one 10 (6), e0128310, 2015 | Health Sciences | 26 |
| Molecular epidemiology and current management of Infectious Spleen and Kidney Necrosis Virus (ISKNV) infection in Ghanaian cultured tilapia ANA Ayiku, AA Adelani, P Appenteng, M Nkansa, JM Ngoi, CM Morang'a, ... |
2024 | Aquaculture 581, 740330, 2024 | Health Sciences | 24 |
| The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B T Mesplède, PK Quashie, S Hassounah, N Osman, Y Han, J Liang, ... |
2015 | Aids 29 (12), 1459-1466, 2015 | Health Sciences | 24 |
| Subunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptase HT Xu, M Oliveira, PK Quashie, M McCallum, Y Han, Y Quan, BG Brenner, ... |
2012 | Journal of virology 86 (16), 8422-8431, 2012 | Health Sciences | 24 |
| Rheumatic heart disease burden in Africa and the need to build robust infrastructure IA Aliyu, JA Bala, I Yusuf, TG Amole, BM Musa, G Yahaya, PK Quashie, ... |
2024 | JACC: Advances 3 (12_Part_2), 101347, 2024 | Health Sciences | 23 |
| Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa K Tapela, FO Oyawoye, CO Olwal, PC Opurum, JA Amponsah, ... |
2022 | BMC medicine 20 (1), 370, 2022 | Natural Sciences | 22 |
| A high-throughput assay for HIV-1 integrase 3′-processing activity using time-resolved fluorescence YS Han, P Quashie, T Mesplede, H Xu, K Mekhssian, C Fenwick, ... |
2012 | Journal of virological methods 184 (1-2), 34-40, 2012 | Health Sciences | 22 |
| Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria K Tapela, DA Prah, B Tetteh, F Nuokpem, D Dosoo, A Coker, ... |
2024 | Cell Reports 43 (8), 2024 | Health Sciences | 21 |
| HIV-1 group O resistance against integrase inhibitors A Depatureaux, T Mesplède, P Quashie, M Oliveira, D Moisi, JC Plantier, ... |
2015 | JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (1), 9-15, 2015 | Health Sciences | 21 |
| Population-based sero-epidemiological investigation of the dynamics of SARS-CoV-2 infections in the Greater Accra Region of Ghana BA Mensah, IC Ndong, PK Quashie, E Guichet, B Abuaku, Y Effah-Baafi, ... |
2022 | Scientific Reports 12 (1), 21582, 2022 | Social Sciences | 20 |
| A resveratrol analog termed 3,3′,4,4′,5,5′‐hexahydroxy‐trans‐stilbene is a potent HIV‐1 inhibitor YS Han, PK Quashie, T Mesplède, H Xu, Y Quan, W Jaeger, T Szekeres, ... |
2015 | Journal of medical virology 87 (12), 2054-2060, 2015 | Health Sciences | 20 |
| Dolutegravir maintains a durable effect against HIV replication in tissue culture even after drug washout N Osman, T Mesplede, PK Quashie, M Oliveira, V Zanichelli, ... |
2015 | Journal of Antimicrobial Chemotherapy 70 (10), 2810-2815, 2015 | Health Sciences | 19 |
| A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries MV Humbert, PC Opurum, NJ Brendish, S Poole, P He, I Katis, J Quaye, ... |
2022 | Journal of Infection 84 (1), 48-55, 2022 | Natural Sciences | 17 |
| The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound M Wainberg, K Anstett, T Mesplede, P Quashie, Y Han, M Oliveira |
2014 | Journal of the International AIDS Society 17, 19518, 2014 | Health Sciences | 16 |
| Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer CO Olwal, JM Fabius, L Zuliani-Alvarez, M Eckhardt, GB Kyei, PK Quashie, ... |
2023 | Molecular omics 19 (7), 538-551, 2023 | Health Sciences | 12 |
| Low COVID-19 impact in Africa: the multifactorial Nexus A Udoakang, M Oboh, A Henry-Ajala, C Anyigba, S Omoleke, ... |
2021 | AAS Open Research 4, 47, 2021 | Natural Sciences | 12 |
| Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir HT Pham, BM Alves, S Yoo, MA Xiao, J Leng, PK Quashie, EA Soares, ... |
2021 | Journal of Antimicrobial Chemotherapy 76 (3), 639-647, 2021 | Natural Sciences | 12 |
| Characterization of the drug resistance profiles of integrase strand transfer inhibitors in simian immunodeficiency virus SIVmac239 SA Hassounah, Y Liu, PK Quashie, M Oliveira, D Moisi, BG Brenner, ... |
2015 | Journal of Virology 89 (23), 12002-12013, 2015 | Health Sciences | 11 |
| Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays AA Manu, IA Owusu, FO Oyawoye, S Languon, IA Barikisu, ... |
2024 | Heliyon 10 (10), 2024 | Natural Sciences | 10 |